Billionaire Profile
T
Global Rank
#462

Image: Little, Archibald John, 1838-1908 | Public domain | via Wikimedia Commons

Tse Ping & family

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$7.832B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+5.88% (24h)
Age
74
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Tse Ping, a prominent figure in the pharmaceutical industry, has built a substantial fortune through his ventures in the sector. His career includes founding Sino Biopharmaceutical, a leading drugmaker in China. His net worth of $6.5 billion (as of 2024) reflects his success in the healthcare industry, along with strategic investments in healthcare. Tse's influence extends beyond business; he is recognized for his commitment to philanthropy, with a focus on global health and education. His leadership has guided Sino Biopharmaceutical to compete strongly in the market.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Tse Ping was born into the Dhanin family, a prominent Asian clan. In the 1950s, most of the family immigrated to Thailand, but Tse remained in China. He was sent to the countryside during the Cultural Revolution, missing the opportunity to attend college.

Rise to Success

Tse Ping entered the pharmaceutical industry, where he saw potential in the counter-cyclical nature of the industry. He gained over 21 years of experience in pharmaceutical investment and management. Under his leadership, Sino Biopharmaceutical became a significant competitor in the hepatitis drugs and therapeutic microsphere targeted medicine markets. His progress attracted foreign investors, including Goldman Sachs, who acquired a stake in the company. Sino Biopharmaceutical won the Forbes Asia “Best Under the $1 billion enterprise within the Asia Pacific Region” award in 2005.

Key Business Strategies

Tse Ping focused on acquiring drugmakers to expand his reach. He saw opportunities in the weaknesses of local businesses, investing and developing those companies. His ability to navigate the business landscape has been key to his success.

Philanthropy

Tse Ping is committed to philanthropy, with a focus on global health and education.

Career Milestones

1991-1997

Acquired Drugmakers

Acquired ten drugmakers, investing $12 million for the CP Group.

2005

Forbes Asia Award

Sino Pharmaceuticals won the Forbes Asia “Best Under the $1 billion enterprise within the Asia Pacific Region” award.

2015

Stepped Down as Chairman

Stepped down as chairman of Sino Biopharmaceutical and ceded the role to his daughter, Theresa.

2022

Son Eric rose to CEO

Ping's son Eric rose to CEO.

Philanthropy & Social Impact

Philanthropy

Global Health and Education

Undisclosed

Focused on global health and education.